V Lennerz Selected Research

Melanoma (Melanoma, Malignant)

1/2009

Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

V Lennerz Research Topics

Disease

1	Celiac Disease (Celiac Sprue) 11/2023
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2016
1	Glioma (Gliomas) 01/2009
1	Melanoma (Melanoma, Malignant) 01/2009

Drug/Important Bio-Agent (IBA)

1	Glutens (Glutelin)IBA 11/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2023
1	Anaplastic Lymphoma KinaseIBA 10/2016
1	HLA-A Antigens (HLA-A)IBA 10/2016
1	AntigensIBA 10/2016
1	Peptides (Polypeptides)IBA 10/2016
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2009
1	Caspase 3 (Caspase-3)IBA 01/2009
1	O-(6)-methylguanineIBA 01/2009
1	fotemustine (Muphoran)IBA 01/2009
1	O(6)-benzylguanineIBA 01/2009
1	Temozolomide (Temodar)FDA LinkGeneric 01/2009
1	Carmustine (FIVB)FDA Link 01/2009
1	Dacarbazine (DIC)FDA LinkGeneric 01/2009

Therapy/Procedure

1	Therapeutics 01/2009
1	Drug Therapy (Chemotherapy) 01/2009